Hwail Pharmaceutical Co.Ltd (061250) — Free Cash Flow Generation Index
Hwail Pharmaceutical Co.Ltd (061250) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of ₩5.44 Billion represents 1% of operating cash flow (₩6.82 Billion). Read debt load of Hwail Pharmaceutical Co.Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hwail Pharmaceutical Co.Ltd Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for Hwail Pharmaceutical Co.Ltd across 10 annual periods. Explore capital reinvestment ratio of Hwail Pharmaceutical Co.Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hwail Pharmaceutical Co.Ltd (2011–2024)
Year-by-year Free Cash Flow Generation Index for Hwail Pharmaceutical Co.Ltd. For the full company profile including market capitalisation, see 061250 market cap overview.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.98x | ₩-23.00 Billion | ₩11.63 Billion | ₩34.63 Billion | ▼ -382.1% |
| 2023 | 0.70x | ₩4.92 Billion | ₩7.02 Billion | ₩2.10 Billion | ▼ -20.1% |
| 2021 | 0.88x | ₩17.62 Billion | ₩20.09 Billion | ₩2.47 Billion | ▼ -32.2% |
| 2019 | 1.29x | ₩4.78 Billion | ₩3.69 Billion | ₩1.09 Billion | ▲ +6.4% |
| 2018 | 1.22x | ₩8.72 Billion | ₩7.17 Billion | ₩1.55 Billion | ▲ +14.6% |
| 2017 | 1.06x | ₩8.85 Billion | ₩8.34 Billion | ₩513.62 Million | ▲ +1.8% |
| 2016 | 1.04x | ₩9.99 Billion | ₩9.58 Billion | ₩413.00 Million | ▼ -55.0% |
| 2013 | 2.32x | ₩16.16 Billion | ₩6.97 Billion | ₩9.18 Billion | ▼ -73.3% |
| 2012 | 8.69x | ₩8.73 Billion | ₩1.00 Billion | ₩7.72 Billion | ▲ +417.8% |
| 2011 | 1.68x | ₩13.18 Billion | ₩7.86 Billion | ₩5.32 Billion | — |